Multiple sclerosis (MS) is a demyelinating neurological condition. “Demyelinating” means the loss of the protective sheath around nerves in your central nervous system.

MS is "an unpredictable disease of the central nervous system," according to the National Multiple Sclerosis Society. It is characterized by inflammation and damage to myelin, the insulating layer ...

Multiple sclerosis can affect employment in several ways, such as the effects of physical symptoms, cognitive changes, and a lack of understanding or support from employers.

Etta I, Elballushi R, Kolesnyk V, et al. Comparison of Pharmacological Therapies in Relapse Rates in Patients With Relapsing-Remitting Multiple Sclerosis. Cureus. 2023;15 (9):e45454.

Multiple sclerosis symptoms in females may be different or worse than in men. Females may be more likely to experience vision changes, fatigue, and cognitive problems.

"New study finds a promising combined therapy for multiple sclerosis." ScienceDaily. ScienceDaily, 2 October 2024. <www.sciencedaily.com / releases / 2024 / 10 / 241002104543.htm>.

Study: Neuroprotective effect of neuron-specific deletion of the C16 ceramide synthetic enzymes in an animal model of multiple sclerosis. Image Credit: Kateryna Kon/Shutterstock.com ...

How to Use the Kesimpta Sensoready Pen Do not remove the cap until you are ready to inject the dose. Below is a list of things you will need to get ready for the injection. These items are not ...

According to a 2022 study, the estimated total economic burden of multiple sclerosis in the U.S. was $85.4 billion in 2019, with a direct medical cost of $63.3 billion; indirect and nonmedical ...

Frexalimab (Sanofi), a novel, investigational second-generation inhibitor of the CD40 ligand, significantly reduced disease activity in relapsing multiple sclerosis (MS) and was well tolerated in ...